Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes
Get Live Data
630.00    30.00 (5.00%)
Bid:
626.00
Ask:
634.00
Spread: 8.00 (1.278%)
Market Cap: £762.36m
OXB Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biomedica Share Chart

BLOCK LISTING RETURN

1 Jul 2024 11:24

RNS Number : 6149U
Oxford Biomedica PLC
01 July 2024
 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Employee Share Option Scheme

Period of return:

From:

1 January 2024

To:

30 June 2024

Balance of unallotted securities under scheme(s) from previous return:

306,521

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

11,802

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

294,719

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Long Term Incentive Plan

Period of return:

From:

1 January 2024

To:

30 June 2024

Balance of unallotted securities under scheme(s) from previous return:

250,368

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

250,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

107,069

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

393,299

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Deferred Bonus Plan

Period of return:

From:

1 January 2024

To:

30 June 2024

Balance of unallotted securities under scheme(s) from previous return:

268,072

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

50,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

31,281

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

286,791

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

Sharesave Scheme

Period of return:

From:

1 January 2024

To:

30 June 2024

Balance of unallotted securities under scheme(s) from previous return:

339,753

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

NIL

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

339,753

 

Name of contact:

Natalie Walter, Company Secretary

Telephone number of contact:

01865 783000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRRBMMTMTTMBJI
Date   Source Headline
1st Mar 201611:04 amRNSTotal Voting Rights
1st Mar 20169:46 amRNSHolding(s) in Company
1st Mar 20169:44 amRNSHolding(s) in Company
1st Mar 20169:38 amRNSNotice of Preliminary Results date: 28 April 2016
29th Feb 201612:16 pmRNSDirector/PDMR Shareholding
26th Feb 20164:42 pmRNSHolding(s) in Company
25th Feb 20165:16 pmRNSDirector/PDMR Shareholding
25th Feb 20162:46 pmRNSHolding(s) in Company
25th Feb 20162:45 pmRNSDirector/PDMR Shareholding
25th Feb 20169:36 amRNSHolding(s) in Company
23rd Feb 20167:00 amRNSPlacing to raise £8.1 Million
16th Feb 201610:59 amRNSHolding(s) in Company
11th Feb 20164:40 pmRNSSecond Price Monitoring Extn
11th Feb 20164:35 pmRNSPrice Monitoring Extension
2nd Feb 20169:37 amRNSTotal Voting Rights
29th Jan 20167:00 amRNSInitiation of Second CART Programme for Novartis
13th Jan 20167:00 amRNSMHRA approval to manufacture in new facility
5th Jan 20167:00 amRNSDirectorate Change
4th Jan 20167:00 amRNSBlocklisting Interim Review
4th Jan 20167:00 amRNSTotal Voting Rights
21st Dec 20152:11 pmRNSTotal Voting Rights
15th Dec 20157:00 amRNSAppointment of New Chairman
2nd Dec 201511:14 amRNSTotal Voting Rights
30th Nov 201511:32 amRNSHolding(s) in Company
20th Nov 20154:40 pmRNSSecond Price Monitoring Extn
20th Nov 20154:35 pmRNSPrice Monitoring Extension
18th Nov 20159:43 amRNSOXB present at Jefferies Healthcare Conference
13th Nov 20154:35 pmRNSPrice Monitoring Extension
4th Nov 20157:00 amRNSBusiness Update
2nd Nov 20157:00 amRNSTotal Voting Rights
28th Oct 20157:00 amRNSGSK Exercises Option on OXB LentiVector Patents
1st Oct 20154:10 pmRNSTotal Voting Rights
11th Sep 20154:35 pmRNSPrice Monitoring Extension
2nd Sep 20153:12 pmRNSHolding(s) in Company
1st Sep 20157:03 amRNSTotal Voting Rights
27th Aug 20157:00 amRNSInterim Results
6th Aug 20155:16 pmRNSHolding(s) in Company
6th Aug 20157:00 amRNSNotice of Interim Results
3rd Aug 20157:00 amRNSTotal Voting Rights
1st Jul 20158:54 amRNSDirector/PDMR Shareholding
1st Jul 20157:00 amRNSBlocklisting Interim Review
1st Jul 20157:00 amRNSTotal Voting Rights
30th Jun 20159:13 amRNSDirector/PDMR Shareholding
25th Jun 20153:40 pmRNSOxford BioMedica Block listing Application
23rd Jun 201512:00 pmRNSOXB to present at JMP Securities
19th Jun 201510:26 amRNSDirector/PDMR Shareholding
17th Jun 20151:21 pmRNSDirector/PDMR Shareholding
16th Jun 20152:03 pmRNSDirector/PDMR Shareholding
15th Jun 201511:23 amRNSDirector/PDMR Shareholding
15th Jun 201511:22 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.